quizartinib
daiichi sankyo
['quizartinib', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'quantum-first']
#eha22 #leusm erba: quizartinib quantum-first ph3 rct (7+3 +/- quiz days 8-21) for flt3-itd+ aml. age 18-75. quiz is type ii flt3i only active against flt3-itd. up to 3yr quiz maintenance permitted. n=265v268 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)